EVH (Evolent Health, Inc Class A Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by EVH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Daniel Joseph McCarthy | PRESIDENT | Sell | — | — |
| 2026-07-06 | Seth Blackley | Chief Executive Officer | MIXED | — | — |
| 2026-07-06 | Aammaad Shams | Chief Accounting Officer | A | — | — |
| 2026-07-06 | Jonathan Weinberg | General Counsel | MIXED | — | — |
| 2026-07-06 | Daniel Joseph McCarthy | PRESIDENT | MIXED | — | — |
| 2026-06-08 | Craig A. Barbarosh | Director | A | — | — |
| 2026-06-08 | Brendan B Springstubb | Director | A | — | — |
| 2026-06-08 | Jill D. Smith | Director | A | — | — |
| 2026-06-08 | PETER J GRUA | Director | A | — | — |
| 2026-06-08 | SHAWN M GUERTIN | Director | A | — | — |
| 2026-06-08 | Russell Monroe Glass | Director | A | — | — |
| 2026-06-08 | KIM KECK | Director | A | — | — |
| 2026-06-08 | Toyin Ajayi | Director | A | — | — |
| 2026-06-08 | Richard M Jelinek | Director | A | — | — |
| 2026-03-04 | Mario Ramos | Chief Financial Officer | A | — | — |
| 2026-03-04 | Daniel Joseph McCarthy | PRESIDENT | MIXED | — | — |
| 2026-03-04 | Seth Blackley | Chief Executive Officer | MIXED | — | — |
| 2026-03-04 | Aammaad Shams | Chief Accounting Officer | MIXED | — | — |
| 2026-03-04 | Jonathan Weinberg | General Counsel | MIXED | — | — |
| 2026-01-06 | Jill D. Smith | Director | A | — | — |
| 2026-01-05 | Mario Ramos | Chief Financial Officer | A | — | — |
| 2025-11-19 | Brendan B Springstubb | Director | Buy | — | — |
| 2025-08-05 | Aammaad Shams | Chief Accounting Officer | F | — | — |
| 2025-07-03 | Daniel Joseph McCarthy | PRESIDENT | A | — | — |
| 2025-07-03 | Jonathan Weinberg | General Counsel | A | — | — |
| 2025-07-03 | John Paul Johnson | Chief Financial Officer | A | — | — |
| 2025-07-03 | Seth Blackley | Chief Executive Officer | A | — | — |
| 2025-06-09 | Craig A. Barbarosh | Director | A | — | — |
| 2025-06-09 | Russell Monroe Glass | Director | A | — | — |
| 2025-06-09 | SHAWN M GUERTIN | Director | A | — | — |
| 2025-06-09 | KIM KECK | Director | A | — | — |
| 2025-06-09 | Cheryl Scott | Director | A | — | — |
| 2025-06-09 | Brendan B Springstubb | Director | A | — | — |
| 2025-06-09 | PETER J GRUA | Director | A | — | — |
| 2025-06-09 | Richard M Jelinek | Director | A | — | — |
| 2025-06-09 | Toyin Ajayi | Director | A | — | — |
| 2025-03-10 | Brendan B Springstubb | Director | Buy | — | — |
| 2025-03-10 | Seth Blackley | Chief Executive Officer | Buy | — | — |
| 2025-03-10 | Craig A. Barbarosh | Director | Buy | — | — |
| 2025-03-10 | Daniel Joseph McCarthy | PRESIDENT | Buy | — | — |
| 2025-03-10 | Richard M Jelinek | Director | Buy | — | — |
| 2025-03-10 | Russell Monroe Glass | Director | Buy | — | — |
| 2025-03-10 | Diane Holder | Director | Buy | — | — |
| 2025-03-10 | PETER J GRUA | Director | Buy | — | — |
| 2025-03-10 | KIM KECK | Director | Buy | — | — |
| 2025-03-05 | Brendan B Springstubb | Director | MIXED | — | — |
| 2025-03-04 | Jonathan Weinberg | General Counsel | MIXED | — | — |
| 2025-03-04 | John Paul Johnson | Chief Financial Officer | MIXED | — | — |
| 2025-03-04 | Daniel Joseph McCarthy | PRESIDENT | MIXED | — | — |
| 2025-03-04 | Seth Blackley | Chief Executive Officer | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 6,434,283 | — |
| — | 10%+ Owner | 5,128,167 | — |
| — | 10%+ Owner | 3,861,858 | — |
| — | 10%+ Owner | 1,630,061 | — |
| — | Chief Executive Officer | 1,283,064 | — |
| — | Director | 976,816 | — |
| — | PRESIDENT | 655,133 | — |
| — | Chief Financial Officer | 587,500 | — |
| — | Chief Financial Officer | 309,245 | — |
| — | Chief Technology Officer | 286,370 | — |
| — | General Counsel | 284,917 | — |
| — | Chief Medical Officer | 206,269 | — |
| — | Chief Operating Officer | 137,868 | — |
| — | Chief Operating Officer | 136,331 | — |
| — | Director | 123,743 | — |
| — | 10%+ Owner | 120,304 | — |
| — | Director | 102,597 | — |
| — | Director | 99,917 | — |
| — | Chief Accounting Officer | 95,637 | — |
| — | Chief Talent Officer | 95,457 | — |
| — | Director | 95,031 | — |
| — | Director | 93,455 | — |
| — | Director | 92,533 | — |
| — | Chief Financial Officer | 84,088 | — |
| — | Director | 83,393 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EVH quote page; the site-wide leaderboard is on the insider transactions hub.